Derm Mgrs

Discussion in 'Pfizer' started by anonymous, Jul 24, 2018 at 7:12 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    ok randy
     

  2. anonymous

    anonymous Guest

    Anyone have a DBM who’s given any insight on reorg? Can’t imagine Pfizer is keeping all these Derm reps. Mine is pfizerbot and won’t say a word
     
  3. anonymous

    anonymous Guest

    Mine says more calls, more frequently, more programs and creating more positive tension (demand the next 5 starts if you've earned it) will turn the tide.

    He's an idiot though, so we all just nod and growl while he's here and go about our business when he's gone.
     
  4. anonymous

    anonymous Guest

    our Derm DM said we are all safe and there’s no hiring freeze. Is this true?
     
  5. anonymous

    anonymous Guest

    This is TRUE. PCP is impacted by this.
     
  6. anonymous

    anonymous Guest

    DBMS don’t know jack. They aren’t in the loop. Email says all BU & Div are on the table.
     
  7. anonymous

    anonymous Guest

    Best guess is I&I gets Eucrisa back from Cluster 1. Word is based on in independent budgets etc, I&I is paying out of their operating budget to have C1 promote. They are maybe making up 20% of revenue. Wtf! Give each Derm rep the 6 HCPs in each territory that are Rxing and keep all the revenue. Heard that’s what Sr. Leadership is strongly advocating. The bonus is reducing redundancy that has not made a large impact anyway. Win Win.
     
  8. anonymous

    anonymous Guest

    How many reps in the Dermatology Business Unit with only one product?
    My business sense tells me since ours is a new division with Pfizer they can do
    with 1/3 of reps. It seems that the company is going mean and lean our business
    doesn’t fit the vision. The future is Oncology not us folks. Let’s not kid ourselves.
     
  9. anonymous

    anonymous Guest

    there are some Derm products in the pipeline. the limiting factor is how long until they get to market.
     
  10. anonymous

    anonymous Guest

    the real limiting factor is Pfizer leadership. we don't know how to operate in derm, plain and simple.

    Derm is not like PC and it's not like Rheumatology.

    Derm is a different world. They still like to be taken care off and they like to be called on by a single rep that they develop a relationship with. They don't like to be strong armed.

    If we want a good model of how to sell a product to dermatology that doesn't work very well, we should look at Celgene. Those guys are the office favorites every office I have, and I've worked some of these offices longer than they have.
     
  11. anonymous

    anonymous Guest

    Anchor away.
     
  12. anonymous

    anonymous Guest

    As an Derm manager outside of your company, allow me to make some observations. I have been watching for the day when they downsize your team. Here is why:

    -You made a mistake in promoting/shifting managers from within Pfizer's primary care that had no clue of the Derm market.
    -You over paid for the "talent" of derm reps. Your sales reps are NOT worth a 6 figure base.
    -You made the mistake of going after steroids. That was stupid to think that your ointment could replace a mid potent steroid.
    -You made a mistake in wasting your time calling on peds. Anyone with derm experience would have pointed to Valeant's mistake of selling CeraVe to peds. They would have also pointed to Galderma's mistake on bringing Cetaphil and then Excipial to peds. It is a black-hole that will never be filled.
    -You blew your runway money on direct to consumer tv/print advertisement.
    -You blew money going to every trade show and trying to impress people by being a premier vendor. And then you brought your rigid marketing booth that is exciting as watching paint dry.
    -You hired around 150 reps? You should have launched with 40-50 reps.
    -You missed the point that your "barrier repair" product is competing against CeraVe, Cetaphil, Eucerin, and Aveeno. These products can all be found at every retail store for 10-15 bucks.

    You are a decade behind in your sales approach. The days of "share of voice" that made you successful with Lipitor are now your down fall. You should have done your homework before trying to FORCE your way into derm.

    Enjoy your layoffs!
     
  13. anonymous

    anonymous Guest

    You are spot on. But Pfizer doesn’t care, because they are Pfizer. We all know the growth pyramid - ass kissers and yes men/women move up.
     
  14. anonymous

    anonymous Guest

    Your spot on with everything except your last point.

    Pfizer will not lay-off Derm reps. The senior leadership team already told the DMs on Friday everyone in Derm is safe.
     
  15. anonymous

    anonymous Guest

    Not a manager, but a derm rep with another company and from my perspective, Pfizer has been nothing but poison. They have bullied their way into a prized specialty that valued relationships and gotten aggressive demanded Eucrisa starts. Docs I have know for years tell me about it and complain all the time. I've seen offices that were once open to all, close to industry. I have 1 main product and 2 secondary products and I call on my docs about once every 5 weeks. There are 4 different Pfizer reps I run into in my territory. There are just too many of them. You get the impression that they are used to having small territories. I just wish they would go away and I don't even compete with them. They have just fouled the offices.
     
  16. anonymous

    anonymous Guest

    Source please. How do you know this? Seems highly unlikely to be true given the glut or reps and lack of $ coming in etc.

    It’s also correct that Pfizer is fouling offices. They’re intent on imposing their culture on derm. Thus the mess we’re in. Too many true believers talking “share of voice” nonsense. Never did work btw. It was their MHC access that drove Rx seeing docs weekly. Ask ANY doc
     
  17. anonymous

    anonymous Guest

    I already told you. Derm wasn’t put in place for short term success. This division was built for long term sustained partnership and growth.

    My prediction
    Pfizer will buy each and every one of you. It’s what Pfizer does. We are BORG. Your going to be assimilated. Resistance is futile.
     
  18. anonymous

    anonymous Guest

    That’s just Pfizer company line BS. Obviously you have no real information. The derm division has way too many reps and Pfizer is approaching the specialty in completely the wrong way. Current rep levels even with new products is unsustainable. Btw you can’t build relationships with people you’re pestering to death
     
  19. anonymous

    anonymous Guest

    That’s just Pfizer company line BS. Obviously you have no real information. The derm division has way too many reps and Pfizer is approaching the specialty in completely the wrong way. Current rep levels even with new products is unsustainable. Btw you can’t build relationships with people you’re pestering to death
     
  20. anonymous

    anonymous Guest

    Dupixent has 2 to 3 reps calling on the same provider in Derm and Allergy. Go target them instead of placing all the blame on Pfizer.

    Dupixent pays a lot of providers a lot of money to write their $20,000 plus injection. Why don’t you blog about this?